|
⚲
|
| Keyboard |
| Engler Robert
✚
|
|
|---|---|
| CIK # | 0001078452 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001078452] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Halozyme Therapeutics Inc | |
| Engler Robert |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Options to Purchase Common Stock · derivative
|
2014-08-14 | Option exercise | 75,000 | $2.05 | 153,750 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-08-14 | Sell | 35,000 | $9.96 | 348,600 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-08-14 | Option exercise | 75,000 | $2.05 | 153,750 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-05-15 | Option exercise | 150,000 | $4.10 | 615,000 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-05-15 | Sell | 126,700 | $7.56 | 957,852 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock (NSO) · derivative
|
2014-05-15 | Option exercise | 150,000 | $4.10 | 615,000 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-05-13 | Grant | 24,876 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2013-05-16 | Grant | 20,000 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2012-11-29 | Buy | 15,000 | $5.57 | 83,550 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2012-05-03 | Grant | 20,000 | $0.00 |